References

  1. American Thoracic Society and Centers for Disease Control and Prevention. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med. 2000;161:1376-1395.
  2. Andries K, Verhasselt P, Guillemont J. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2005;307:223-227.
  3. Centers for Disease Control and Prevention. Drug-resistant TB. https://www.cdc.gov/tb/topic/drtb/default.htm. Accessed July 1, 2019.
  4. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2017. www.cdc.gov/tb/statistics/reports/2017/2017_Surveillance_FullReport.pdf. Accessed July 1, 2019.
  5. Haagsma AC, Podasca I, Koul A, et al. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase. PLoS One. 2011;6(8):e23575.
  6. Lalloo UG, Ambaram A. New antituberculous drugs in development. Curr HIV/AIDS Rep. 2010;7(3):143–151.
  7. Madariaga MG, Lalloo UG, Swindells S. Extensively drug-resistant tuberculosis. Am J Med. 2008;121(10):835-844.
  8. Matteelli A, Carvalho ACC, Dooley KE, et al. TMC207: the first compound of a new class of potent antituberculosis drugs. Future Microbiol. 2010;5(6):849–858.
  9. World Health Organization. Drug-Resistant TB Surveillance & Response. Supplement to Global Tuberculosis Report 2014. http://apps.who.int/medicinedocs/documents/s21635en/s21635en.pdf. Accessed July 2, 2019.
  10. World Health Organization. Tuberculosis. www.who.int/en/news-room/fact-sheets/detail/tuberculosis. Accessed July 2, 2019.
  11. World Health Organization. Treatment of Tuberculosis Guidelines. 4th edition. apps.who.int/iris/bitstream/handle/10665/44165/9789241547833_eng.pdf?sequence=1. Accessed July 2, 2019.
  12. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. 2011 Update. apps.who.int/iris/bitstream/handle/10665/44597/9789241501583_eng.pdf?sequence=1. Accessed July 2, 2019.
  13. Zignol M, van Gernert W, Falzon D, et al. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis. 2011;52(7):901-906.
  14. Centers for Disease Control and Prevention. Tuberculosis — United States, 2018.
    https://www.cdc.gov/mmwr/volumes/68/wr/mm6811a2.htm
    Accessed October 14, 2019.